JNJ Shareholder Files Plan to Sell 15,918 Shares Worth $4.09M

A Johnson & Johnson shareholder has filed a notice to sell 15,918 shares of common stock under Rule 144. The planned sale covers an aggregate market value of $4,090,957.06 and is set to occur on or after August 6, 2026, on the NYSE.

The shares being sold derive from a stock option exercise dated August 6, 2026, which granted 9,344 shares, as well as multiple restricted stock vesting events between July 1, 2022, and February 14, 2025, totaling 6,574 shares.

The filing lists no securities sold during the past three months. This information is publicly available on EDGAR, with the Form 144 accepted by the SEC on August 6, 2026.